PHILADELPHIA — (July 25, 2024) — The Wistar Institute honors 2023 Nobel Prize laureate in Physiology or Medicine Katalin Karikó, Ph.D., as the 2024 Helen Dean King Award recipient. Dr. Karikó, prof…
PHILADELPHIA — (July 16, 2024) —The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute — is creating a new …
PHILADELPHIA — (July 10th, 2024) —On Tuesday, July 16th at 6:30 pm EDT, Nobel Laureate in Medicine or Physiology Drew Weissman, M.D., Ph.D., — Roberts Family Professor in Vaccine Research, Director…
PHILADELPHIA — (July 10, 2024) — The Wistar Institute (“Wistar”) is pleased to announce a research collaboration with Accelerated Biosciences Corp. (“Accelerated Bio”) aimed at creating a groundbre…
PHILADELPHIA — (July 1, 2024) —The Wistar Institute is pleased to announce the appointment of Jozef Madzo, Ph.D., to the faculty as an assistant professor and Director of Bioinformatics. Dr. Madzo …
PHILADELPHIA — (Thursday, June 27, 2024) — The Wistar Institute’s Noam Auslander, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer …
PHILADELPHIA — (June 18, 2024) — The Wistar Institute received a $10 million donation from an anonymous donor who previously committed $20 million to support Wistar’s new Center for Advanced Therap…
PHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 …
PHILADELPHIA — (May 28, 2024) — The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B cells i…
The West Philadelphia Skills Initiative, The Wistar Institute, PIDC, The Chamber of Commerce for Greater Philadelphia, Iovance Biotherapeutics, and Integral Molecular Began Joint Recruitment May 21…
